OpenVSafe by OpenVAERS
Search V-safe

Y99-14221-84054

3 vaccinations 5 coded responses 26 check-ins 5 free-text entries 2 call cases
Sex
Female
Age at first dose
61-65
ZIP prefix
080 / NJ
Registered
2021-01-22
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-21
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-22
    Registered in v-safe
  3. 2021-01-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-01-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-01-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-28
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-02-04
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-02-11
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-02-13
    Dose 2 — Pfizer-BioNTech
  13. 2021-02-14
    Survey response — days 1–6 daily, dose 2
    MedDRA: Injection site erythema, Injection site pain, Injection site swelling — Feeling: Fair · Site: Pain, Redness, Swelling · Joint pains, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Injection site swelled to golf ball size, red, and painful. Limited ROM by affected extremity. Improving 36 hrs post-injection.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-02-15
    Survey response — days 1–6 daily, dose 2
    MedDRA: Injection site discomfort, Injection site erythema, Injection site swelling — Feeling: Good · Site: Pain, Redness
    Free text: Swelling from yesterday markedly decreased at injection site. Site remains red with mild discomfort; nothing like the day before.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-02-16
    Survey response — days 1–6 daily, dose 2
    MedDRA: Pruritus — Feeling: Good · Site: Redness, Itching
    Free text: Itchiness much improved over past 24 hrs.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-02-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Redness, Swelling, Itching · None
    Adult check-in
  17. 2021-02-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-02-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-02-20
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-02-27
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-03-06
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-03-13
    Survey response — day 28, dose 2
    MedDRA: Pruritus, Self-medication — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Generalized, all over body itching for past 2 weeks. Worsening in 2nd week to the point of taking Benadryl and prednisone for relief.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-03-13
    Report sent to call center — day 28, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  24. 2021-03-20
    Survey response — day 35, dose 2
    MedDRA: Pruritus, Self-medication — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Generalized, overall itchiness has returned. Back to taking Benadryl and prednisone for relief.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  25. 2021-03-20
    Report sent to call center — day 35, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  26. 2021-03-27
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-05-15
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  28. 2021-08-14
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  29. 2021-11-06
    Dose 3 — Pfizer-BioNTech
  30. 2021-12-21
  31. 2022-02-13
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in
  32. 2022-05-07
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  33. 2022-11-06
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-21Pfizer-BioNTech
22021-02-13Pfizer-BioNTech
32021-11-06Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2021-03-13 Unsuccessful
2021-03-20 Unsuccessful

Free text

Release 4 — days 1–6 daily, dose 2

2021-02-14

Systemic reaction (other): Injection site swelled to golf ball size, red, and painful. Limited ROM by affected extremity. Improving 36 hrs post-injection.

2021-02-15

Systemic reaction (other): Swelling from yesterday markedly decreased at injection site. Site remains red with mild discomfort; nothing like the day before.

2021-02-16

Systemic reaction (other): Itchiness much improved over past 24 hrs.

Release 5 — day 28, dose 2

2021-03-13

Symptoms: Generalized, all over body itching for past 2 weeks. Worsening in 2nd week to the point of taking Benadryl and prednisone for relief.

Release 6 — day 35, dose 2

2021-03-20

Symptoms: Generalized, overall itchiness has returned. Back to taking Benadryl and prednisone for relief.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDPruritus ✓ ✓ ✓
SDSelf-medication ✓ ✓ ✓
SROInjection site discomfort ✓ ✓ ✓
SROInjection site erythema ✓ ✓ ✓
SROInjection site pain ✓ ✓ ✓
SROInjection site swelling ✓ ✓ ✓
SROPruritus ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release